1766-1767 / 2437
Primary endpoint: tumor size at 3 and 6 months after surgery:
no difference between study arms
Progression-free survival
Overall survival
Stragliotto et al., Int J Cancer 2013
VIGAS study: o
utcome
|
|
1766-1767 / 2437
Primary endpoint: tumor size at 3 and 6 months after surgery:
no difference between study arms
Progression-free survival
Overall survival
Stragliotto et al., Int J Cancer 2013
VIGAS study: o
utcome